EFFECTS OF A POTASSIUM-SPARING THIAZIDE DIURETIC COMBINATION ON CARDIOVASCULAR REACTIVITY TO VASOPRESSOR AGENTS

被引:4
|
作者
SCHOHN, DC [1 ]
JAHN, HA [1 ]
机构
[1] UNIV STRASBOURG 1,DEPT NEPHROL & HEMODIALYSIS,F-67070 STRASBOURG,FRANCE
来源
AMERICAN JOURNAL OF CARDIOLOGY | 1990年 / 65卷 / 23期
关键词
D O I
10.1016/0002-9149(90)91270-G
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The vascular effects of a diuretic combination (spironolactone/altizide) were studied in S anuric patients undergoing dialysis by measuring changes in cardiovascular reactivity to norepinephrine (NE) and angiotensin II (AII) after infusion of incremental doses of these 2 vasopressor agents. There was a marked dose-response relation between NE and AII administration and mean (NE) or diastolic (AII) blood pressure (BP). Diuretic treatment moderated the increase in mean or diastolic BP induced by NE or AII. In addition, the pressor doses of NE and AII, which are also parameters of vascular reactivity, were significantly increased after diuretic treatment (NE, +101%; AII, +163%). Right atrial and pulmonary capillary wedge pressures increased along with BP in response to NE. Diuretic treatment also moderated the increase in right atrial and pulmonary capillary wedge pressures induced by NE. These results suggest that the antihypertensive action of spironolactone and altizide in combination is mainly due to a direct effect on resistance and capacitance vessels. The mechanisms by which diuretics modify the cardioreactivity remain poorly understood; however, they may modify electrolyte transport (sodium and calcium) across vascular smooth muscle cell membranes or stimulate postaglandin release. © 1990.
引用
收藏
页码:K14 / K17
页数:4
相关论文
共 50 条
  • [31] MECHANISM OF ACTION, PHARMACOKINETICS, ADVERSE-EFFECTS, AND THERAPEUTIC USES OF AMILORIDE HYDROCHLORIDE, A NEW POTASSIUM-SPARING DIURETIC
    VIDT, DG
    PHARMACOTHERAPY, 1981, 1 (03): : 179 - 187
  • [32] Potassium-sparing effects of furosemide in mice on high-potassium diets
    Wang, Bangchen
    Sansom, Steven C.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2019, 316 (05) : F970 - F973
  • [35] KALEMIA DURING COMBINED THERAPY WITH AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR AND A POTASSIUM-SPARING DIURETIC
    MOOSER, V
    WAEBER, G
    BIDIVILLE, J
    WAEBER, B
    NUSSBERGER, J
    BRUNNER, HR
    JOURNAL OF CLINICAL HYPERTENSION, 1987, 3 (04): : 510 - 513
  • [36] Diuretic and potassium-sparing effect of isoquercitrin-An active flavonoid of Tropaeolum majus L.
    Gasparotto Junior, Arquimedes
    Gasparotto, Francielly Mourao
    Boffo, Marcos Aurelio
    Botelho Lourenco, Emerson Luiz
    Alves Stefanello, Maria Elida
    Salvador, Marcos Jose
    da Silva-Santos, Jose Eduardo
    Andrade Marques, Maria Consuelo
    Leite Kassuya, Candida Aparecida
    JOURNAL OF ETHNOPHARMACOLOGY, 2011, 134 (02) : 210 - 215
  • [37] A SULPHONYLTHIOUREA (BM 20) RELATED TO TORASEMIDE - A NEW LOOP DIURETIC WITH RELATIVE POTASSIUM-SPARING PROPERTIES
    MASEREEL, B
    SCHYNTS, M
    KRZESINSKI, JM
    PIROTTE, B
    RORIVE, G
    DELARGE, J
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (08) : 720 - 724
  • [38] Discovery of small-molecule inhibitors of ROMK: one step closer to a potassium-sparing loop diuretic?
    Denton, Jerod
    Lewis, L. Michelle
    Banerjee, Sreedatta
    Fallen, Katherine
    Redha, Rey
    Lornsen, Katharina A.
    Weaver, C. David
    FASEB JOURNAL, 2009, 23
  • [39] EXAMINATION OF POTASSIUM-SPARING EFFECTS OF TRIAMTERENE VERSUS AMILORIDE IN HYDROCHLOROTHIAZIDE THERAPY
    GLEZER, GA
    MERZON, AK
    LIPKO, DS
    DONSKOVA, TV
    LEVINZON, AM
    SHELEST, YP
    KLINICHESKAYA MEDITSINA, 1990, 68 (09): : 61 - 64
  • [40] Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents
    Tamargo, Juan
    Segura, Julian
    Ruilope, Luis M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (05) : 605 - 621